Witkiewicz AK, Wang J, Schultz E, O'Connor TN, et al. Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer. Oncogene 2025 Feb 26. doi: 10.1038/s41388-025-03308.
PMID: 40011574